Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB)
eMOB
2 other identifiers
interventional
700
1 country
1
Brief Summary
Physical activity (PA) and sedentary lifestyle are determinants in the development of chronic diseases and associated quality of life alterations. PA levels are correlated with quality of life and morbidity in chronic lung disease (COPD), cardiovascular disease, diabetes, cancer, chronic inflammatory rheumatism, fibromyalgia and anxiety disorders. In these diseases, low-intensity PA often represents the main PA and the quantity of PA is correlated with health parameters. This study aims to identify a typical profile (signature) in relation to the appearance of other chronic diseases, complications of your disease, from recording your physical activity and sedentary lifestyle by sensors evaluating very precisely the movements and taking into account the characteristics and disability related to your disease. The results of this study would therefore make it possible to identify this signature even before the appearance of complications or other diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedStudy Start
First participant enrolled
December 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
September 24, 2025
September 1, 2025
7 years
September 19, 2022
September 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Occurrence of one additional comorbidity in patients with chronic diseases.
Association of a digital signature of PA and sedentary lifestyle with the development of at least one additional comorbidity over 4 years of follow-up.
year 4
Digital signature of sedentary lifestyle and PA in patients with chronic diseases.
A sensor of movement will be worn by the patients for 5 days every 4 months during the study, to detect and quantify the physical activity and the sedentarity according to their intensity. This sensor will be accelerometer, allowing the acquisition of movements second by second. The analysis of the data from the sensors, the occurrence of a new comorbidity, the clinical data will allow to establish an algorithm to define a profile (digital signature) of occurrence of a new chronic disease.
Year 4
Secondary Outcomes (20)
Occurence of multimorbidity in patients with chronic diseases.
Year 1
Occurence of multimorbidity in patients with chronic diseases.
year 2
Occurence of multimorbidity in patients with chronic diseases.
Year 3
Occurence of multimorbidity in patients with chronic diseases.
Yaer 4
Correlation of PA/sedentary signature with destabilization or improvement/stability of the chronic condition.
Year 1
- +15 more secondary outcomes
Study Arms (1)
Chronic diseases
OTHERCohort Study
Interventions
Patients will wear an accelerometer 3 times a year for 5 days (3 weekdays and 2 weekend days), the data will be collected
Eligibility Criteria
You may qualify if:
- Patient follow-up at CHU Clermont-Ferrand for a chronic disease in one of the following observational cohorts:
- Inflammatory rheumatic disease(rheumatoid arthritis, spondyloarthritis) included in the RCVRIC cohort (CPP Sud-Est VI N° ID-RCB- A01847-40)
- Pre-surgical knee and hip osteoarthritis (Evalmob) (ID-RCB N° 2019- A01017-50)
- Major depressive disorder included in the FACE-DR cohort (CNIL agreement: DR- 2015-673) and Bipolar disorder included in the FACE-BD cohort (CPP Ile de France IX; January 18, 2010) of the Adult Psychiatry Department B
- Type 2 diabetes included in the cohort of the sport medicine service "Rehabilitation T2" (CNIL agreement 0164)
- Obesity included in the "Obesity" sports medicine service cohort (CNIL agreement 0164)
- COPD included in the "COPD Rehabilitation" sports medicine service cohort (CNIL agreement 0164)
- Chronic pain cohort (eDOL) (CPP West II N° ID-RCB 2020-A02027-32)
- Affiliation to a social security system.
- Able to provide written informed consent to participate in the research.
You may not qualify if:
- Inability to practice physical activity
- Pregnant or breastfeeding
- Refusal to participate
- Minors or adults under the protection of the law or under the protection of justice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Tournadre
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2022
First Posted
October 13, 2022
Study Start
December 7, 2023
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
September 24, 2025
Record last verified: 2025-09